Clinical Trials Directory

Trials / Sponsors / DBV Technologies

DBV Technologies

Industry · 16 registered clinical trials1 currently recruiting.

StatusTrialPhaseStarted
RecruitingSafety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
Allergy, Peanut Allergy
Phase 32025-06-24
Active Not RecruitingSafety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
Allergy, Peanut
Phase 32023-02-21
UnknownDiagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children
Cow's Milk Allergy
Phase 22020-08-28
CompletedFollow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children
Peanut Allergy
Phase 32018-12-06
CompletedA Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Su
Peanut Allergy
Phase 12017-11-24
CompletedSafety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age
Peanut Allergy
Phase 32017-07-31
UnknownFollow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children
Peanut Allergy
Phase 32017-01-23
CompletedSafety Study of Viaskin Peanut to Treat Peanut Allergy
Peanut Allergy
Phase 32016-10-01
CompletedViaskin Pertussis Vaccine Trial
Whooping Cough
Phase 12016-09-05
CompletedEfficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Peanut Allergy
Phase 32015-12-01
CompletedEfficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy
Food Allergy
Phase 1 / Phase 22014-11-01
CompletedFollow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children
Peanut Allergy
Phase 22013-09-01
CompletedEfficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
Peanut Allergy
Phase 22012-08-01
CompletedSafety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy
Peanut Allergy
Phase 12010-07-01
No Longer AvailableViaskin® Peanut (DBV712) Expanded Access Protocol
Peanut Allergy
AvailableExpanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children
Peanut Allergy